Search results for "Witch"

showing 10 items of 542 documents

Canal switch and re-entry phenomenon in benign paroxysmal positional vertigo: difference between immediate and delayed occurrence

2014

Studio prospettico ideato per la valutazione delle differenze tra la conversione canalare o il rientro degli otoliti nei canali semicircolari successivo alle manovre terapeutiche nei pazienti affetti da VPPB. Sono stati valutati 196 pazienti affetti da VPPB, 127 dei quali corrispondevano ai criteri di inclusione. L’età media dei pazienti era di 54.74 anni. Il canale orizzontale è stato coinvolto in 30 casi e il canale posteriore in 97 pazienti. I pazienti con sordità neurosensoriale presentavano forme ricorrenti di VPPB, rispetto a quelli con udito normale. L’immediato rientro canalare è stato diagnosticato in 3 pazienti con VPPB del canale laterale, tutti con nistagmo geotropo. 7 pazienti …

MaleBenign paroxysmal positional vertigo; Canal conversion; Dizziness; Vertigo; canal switchTime FactorsDizzinecanal switchMiddle AgedSettore MED/42 - Igiene Generale E ApplicataCanal conversionDizzinessVestibologyOtolithic Membraneotorhinolaryngologic diseasesVertigoHumansFemalesense organsProspective StudiesBenign paroxysmal positional vertigo
researchProduct

Absence of an aging-related increase in fiber type grouping in athletes and non-athletes

2020

The ageing-related loss of muscle mass is thought to be partly attributable to motor neuron loss and motor unit remodelling that result in fibre type grouping. We examined fibre type grouping in 19- to 85-year-old athletes and non-athletes and evaluated to which extent any observed grouping is explained by the fibre type composition of the muscle. Since regular physical activity may stimulate reinnervation, we hypothesised that fibre groups are larger in master athletes than in age-matched non-athletes. Fibre type grouping was assessed in m. vastus lateralis biopsies from 22 young (19-27 years) and 35 healthy older (66-82 years) non-athletes, and 14 young (20-29 years), 51 middle-aged (38%6…

MaleBiopsy030204 cardiovascular system & hematologyMuskel- und KnochenstoffwechselQuadriceps Muscleudc:612.74:612.660302 clinical medicinegroupingOrthopedics and Sports MedicineFibre typeAged 80 and overMotor NeuronsDenervationbiologyFiber typestaranjemišična vlaknaMiddle Agedfibre typeMuscle Fibers Slow-Twitchmedicine.anatomical_structureMuscle Fibers Fast-TwitchreinervacijaFemaleSportsReinnervationAdultmedicine.medical_specialtyPhysical Therapy Sports Therapy and RehabilitationYoung Adult03 medical and health sciencesInternal medicinevastus lateralismedicineHumansAgeddenervationbusiness.industryAthletesaging030229 sport sciencesMotor neuronbiology.organism_classificationfiber typereinnervationMotor unitdenervacijaCross-Sectional StudiesEndocrinologyAgeingbusiness
researchProduct

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabin…

2019

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. At week 52 participants in the boosted PI arm were offered switch to D/C/F/TAF (late-switch, 44 weeks D/C/F/TAF exposure). All participants were followed on D/C/F/TAF until week 96. Efficacy endpoints were percentage cumulative protocol-defined virologic rebound (PDVR; confirmed vira…

MaleDOLUTEGRAVIRSustained Virologic ResponseHIV InfectionsGastroenterologychemistry.chemical_compound0302 clinical medicineMedicine and Health SciencesEmtricitabine030212 general & internal medicinePharmacology & PharmacyDarunavir0303 health sciencesAlanineDrug SubstitutionCobicistatEmtricitabine Tenofovir Disoproxil Fumarate Drug CombinationLamivudineAntiretroviralsMiddle AgedViral LoadOPEN-LABEL3. Good healthWEIGHT-GAINDrug CombinationsTreatment OutcomeDolutegravirNON-INFERIORITYFemaleSafetyViral loadLife Sciences & Biomedicinemedicine.drugTabletsAdultmedicine.medical_specialtyEfficacyAnti-HIV AgentsRITONAVIREmtricitabineTENOFOVIR ALAFENAMIDELAMIVUDINETenofovir alafenamideSingle-tablet regimen03 medical and health sciencesInternal medicineVirologymedicineVIH (Virus)HumansSwitch studyProtease InhibitorsTenofovirDarunavirAgedPharmacologyScience & Technology030306 microbiologybusiness.industryHIV (Viruses)AdenineDarunavir/cobicistat/emtricitabine/TAFAntiretroviral agentsCOBICISTATMAINTENANCEchemistry[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieHIV-1RitonavirCobicistat[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessRESISTANCE
researchProduct

Novel slow-skeletal myosin (MYH7) mutation in the original myosin storage myopathy kindred

2006

Abstract Myosin storage myopathy (OMIM 608358), a congenital myopathy characterised by subsarcolemmal, hyaline-like accumulations of myosin in Type I muscle fibres, was first described by Cancilla and Colleagues in 1971 [Neurology 1971;21:579–585] in two siblings as ‘familial myopathy with probable lysis of myofibrils in type I muscle fibres'. Two mutations in the slow skeletal myosin heavy chain gene ( MYH7 ) have recently been associated with the disease in other families. We have identified a novel heterozygous Leu1793Pro mutation in MYH7 in DNA from paraffin sections of one of the original siblings. This historical molecular analysis confirms the original cases had myosin storage myopat…

MaleHeterozygotemacromolecular substancesMyosinsBiologymedicine.disease_causeMuscular DiseasesMyofibrilsMyosinmedicineHumansMyopathyGeneGenetics (clinical)GeneticsMutationMyosin Heavy ChainsMyosin storage myopathyDNAExonsmedicine.diseaseMolecular biologyCongenital myopathyMuscle Fibers Slow-TwitchNeurologyChild PreschoolMutationPediatrics Perinatology and Child HealthFemaleMYH7Neurology (clinical)medicine.symptomMyofibrilCardiac MyosinsNeuromuscular Disorders
researchProduct

Behavioral and electrophysiological correlates of cognitive control in ex-obese adults

2017

Impaired cognitive control functions have been documented in obesity. It remains unclear whether these functions normalize after weight reduction. We compared ex-obese individuals, who successfully underwent substantial weight loss after bariatric surgery, to normal-weight participants on measures of resistance to interference, cognitive flexibility and response inhibition, obtained from the completion of two Stroop tasks, a Switching task and a Go/NoGo task, respectively. To elucidate the underlying brain mechanisms, event-related potentials (ERPs) in the latter two tasks were examined. As compared to controls, patients were more susceptible to the predominant but task-irrelevant stimulus …

MaleInhibition (Psychology)Bariatric surgery; ERP; Inhibition; Obesity; Stroop; SwitchingAudiologyDevelopmental psychologyTask (project management)CognitionPostoperative Complications0302 clinical medicineWeight lossPostoperative PeriodEvoked PotentialsInhibitionGeneral Neuroscience05 social sciencesCognitive flexibilityBrainElectroencephalographyCognitionMiddle AgedInhibition PsychologicalNeuropsychology and Physiological PsychologyFemaleStroopEvoked Potentialmedicine.symptomCase-Control StudiePsychologypsychological phenomena and processesERPHumanAdultmedicine.medical_specialtyStimulus (physiology)behavioral disciplines and activities050105 experimental psychologyYoung Adult03 medical and health sciencesSettore M-PSI/08 - Psicologia ClinicaWeight LossReaction TimemedicineHumansCognitive Dysfunction0501 psychology and cognitive sciencesObesityBariatric surgeryNeuroscience (all)Settore M-PSI/02 - Psicobiologia E Psicologia Fisiologicamedicine.diseaseObesityWeight LoElectrophysiologyCase-Control StudiesStroop TestSwitchingPostoperative Complication030217 neurology & neurosurgeryStroop effect
researchProduct

Effects of 7-OH-DPAT and U 99194 on the behavioral response to hot plate test, in rats

2005

Aim of present study was to investigate in male Wistar rats, whether behavioral response to hot plate test application could be influenced by systemic administration of 7-OH-DPAT, a dopaminergic (DA) D3 versus D2 receptor agonist, or U 99194, a DA D3 versus D2 receptor antagonist. Each trial lasted no more than 10 s and the whole experimental session lasted 120 min. Animal behavior was recorded by means of a digital videocamera and later, frame by frame examined using a professional videorecorder. Latency of each behavioral pattern, characterizing the response, was analysed, showing significant changes only with U 99194. A multivariate cluster analysis indicated the presence of three main b…

MalePain ThresholdAgonistmedicine.medical_specialtyHot TemperatureDopaminergic D3 receptorTetrahydronaphthalenesmedicine.drug_classDopamine AgentsExperimental and Cognitive Psychology7-OH-DPATSettore BIO/09 - FisiologiaBehavioral Neurosciencechemistry.chemical_compoundDopamine receptor D3Dopamine receptor D2Internal medicineAvoidance LearningReaction TimemedicineAnimalsCluster AnalysisRats WistarHot plate testNeurotransmitterBehavioral switching7-OH-DPATStochastic ProcessesBehavior AnimalReceptors Dopamine D2U 99194DopaminergicBehavioral patternRatsEndocrinologychemistryIndansRatPsychologyLearning processePhysiology & Behavior
researchProduct

Platform switch versus platform match in the posterior mandible – 1-year results of a multicentre randomized clinical trial.

2014

Objective The purpose of this ongoing randomized study was to assess differences in bone level changes and success rates using implants supporting single crowns in the posterior mandible either with platform matched or platform switched abutments. Material and Methods Patients aged 18 and above, missing at least two teeth in the posterior mandible and with a natural tooth mesial to the most proximal implant site were enrolled. Randomization followed implant placement. Definitive restorations were placed after a minimum transgingival healing period of 8 weeks. Changes in crestal bone level from surgery and loading (baseline) to 12-month post-loading were radiographically measured. Implant su…

MalePlatform switchingDentistryMandiblelaw.inventioncrestal bone preservationDental Implants Single-ToothRandomized controlled triallawBone DensitymedicineAlveolar ProcessHumansPeriodontal PocketDental Restoration FailureProspective StudiesBone levelCementationRadiography BitewingOrthodonticsPosterior mandibleCrownsbusiness.industryplatform matchingplatform switchingAlveolar processDental prosthesisDental Plaque IndexMandibleDental Implant-Abutment DesignSingle toothMiddle Agedrandomized clinical trialSurvival Analysismedicine.anatomical_structureTreatment OutcomeTorqueimplant successPeriodonticsFemaleBone RemodelingDental Prosthesis Implant-SupportedPeriodontal IndexbusinessImplant TherapyFollow-Up StudiesJournal of clinical periodontology
researchProduct

Effect of platform switching on crestal bone levels around implants in the posterior mandible: 3 years results from a multicentre randomized clinical…

2016

Objective Evaluation of differences in the clinical performance and crestal bone levels between implants restored with single crowns with platform-matched or platform-switched abutments after 3 years. Material and Methods The study enrolled adult patients missing two or more adjacent teeth in the posterior mandible with natural teeth mesial to the implant site. Randomization followed open-flap implant insertion and the corresponding matching or switching healing abutments placed at surgery. Conventional loading was made with cemented crowns. Clinical follow-up took place annually after loading up to 3 years. Bone level changes were measured in standardized radiographs as the variation in cr…

MaleRandomizationimplantRadiographyPlatform switchingAlveolar Bone LossDentistryDental AbutmentsMandiblelaw.inventioncrestal bone preservation03 medical and health sciences0302 clinical medicineRandomized controlled trialDental AbutmentslawMedicineHumansstandardized radiographDental ImplantsCrestal boneCrownsbusiness.industryplatform switchingDental Implantation EndosseousMandiblebone level030206 dentistryMiddle AgedDental Prosthesis Designimplant success030220 oncology & carcinogenesisRandomized Clinical Trialplatform matchPeriodonticsFemaleImplantbusinessImplant TherapyFollow-Up StudiesJournal of clinical periodontology
researchProduct

Changes of QTc interval after opioid switching to oral methadone.

2013

Abstract A consecutive sample of patients who were switched from strong opioids to methadone in a period of 1 year was surveyed. QTc was assessed before switching (T0) and after achieving adequate analgesia and an acceptable level of adverse effects (Ts). Twenty-eight of 33 patients were switched to methadone successfully. The mean initial methadone doses at T0 were 67.1 mg/day (SD ±80.2, range 12-390). The mean QTc interval at T0 was 400 ms (SD ±30, range 330-450). The mean QTc interval at Ts (median 5 days) was 430 ms (SD ±26, range 390-500). The difference (7.7 %) was significant (p < 0.0005). Only two patients had a QTc of 500 ms. No serious arrhythmia was observed. At the linear regres…

MaleRiskCancer pain; Methadone; QT prolongation; Toxicity; Opioid switchingPainSettore MED/41 - AnestesiologiaQT prolongationSettore MED/42 - Igiene Generale E ApplicataQT intervalCONSECUTIVE SAMPLEElectrocardiographyNeoplasmsOpiate Substitution TreatmentmedicineHumansIn patientcardiovascular diseasesCancer painAdverse effectAgedToxicitybusiness.industryMiddle AgedAnalgesics OpioidLong QT SyndromeOncologyOpioidAnesthesiaToxicityLinear Modelscardiovascular systemOpioid switchingFemaleCancer painbusinessMethadoneMethadonemedicine.drug
researchProduct

Electrophysiological correlates of the cognitive control processes underpinning mixing and switching costs

2016

Typically, in task-switching contexts individuals are slower and less accurate when repeating a task in mixed blocks compared to single-task blocks (mixing cost) and when switching to a new task compared to repeating a previous one (switch cost). Previous research has shown that distinct electrophysiological correlates underlie these two phenomena. However, this evidence is not a consistent result. The goal of this study was to better characterize differences between the control processes involved in mixing and switch costs. To this aim, we examined event-related potentials (ERPs) evoked during a cued task-switching experiment. In order to minimize the confounding effects of cognitive deman…

MaleTask switchingTask-setElectroencephalographyCueTask (project management)Developmental psychologyExecutive Function0302 clinical medicineCognitionEvoked PotentialsMixing (physics)Cerebral Cortexmedicine.diagnostic_testGeneral Neuroscience05 social sciencesCognitionElectroencephalographyExecutive functionsexecutive functionsERP; cognitive control; executive functions; switch-positivity; task-set; task-switchingCognitive controlFemaleswitch-positivityCuesEvoked PotentialPsychologypsychological phenomena and processesERPCognitive psychologyHumanAdultTask switchingbehavioral disciplines and activities050105 experimental psychology03 medical and health sciencesYoung AdultP3bmedicineReaction TimeHumans0501 psychology and cognitive sciencesMolecular Biologytask-switchingCued speechNeuroscience (all)Settore M-PSI/02 - Psicobiologia E Psicologia FisiologicaSwitch positivityNeurology (clinical)030217 neurology & neurosurgeryPsychomotor PerformanceDevelopmental Biology
researchProduct